10967/261 - QDB Compounds

QsarDB Repository

Zukić, S.; Osmanović, A.; Harej, A.; Kraljević Pavelić, S.; Špirtović-Halilović, S.; Veljović, E.; Roca, S.; Trifunović, S.; Završnik, D.; Maran, U. Data driven modelling of substituted pyrimidine and uracil-based derivatives validated with newly synthesized and antiproliferative evaluated compounds. Int. J. Mol. Sci. 2024, 25, 9390

Compound

ID:T37
Name:CHEMBL244984
Description:
Labels:Train
CAS:
InChi Code:InChI=1S/C32H23BrN2O6/c33-26-15-12-22(13-16-26)11-14-25-19-35(32(38)34-30(25)36)18-17-27-28(39-20-23-7-3-1-4-8-23)29(31(37)41-27)40-21-24-9-5-2-6-10-24/h1-10,12-13,15-17,19H,18,20-21H2,(H,34,36,38)/b27-17-

Properties

pIC50: Antiproliferative activity [-log(uM)] i

ValueSource or prediction
5.1

Gazivoda, T.; Šokčević, M.; Kralj, M.; Šuman, L.; Pavelić, K.; De Clercq, E.; Andrei, G.; Snoeck, R.; Balzarini, J.; Mintas, M.; Raić-Malić, S. Synthesis and Antiviral and Cytostatic Evaluations of the New C-5 Substituted Pyrimidine and Furo[2,3-d]pyrimidine 4‘,5‘-Didehydro-L-ascorbic Acid Derivatives. Journal of Medicinal Chemistry 2007, 50, 4105–4112. http://dx.doi.org/10.1021/jm070324z

4.95709

Eq.1: QSAR model for for antiproliferative activity for HeLa cells (Training set)